The platform, which its developers said is well suited to point-of-care testing, uses fluorescent polymers to distinguish between samples from cases and controls.
To detect clinically relevant levels, the magneto-optic system measured magnetic nanocrystals in rabbit blood created by the malaria parasite.
Years after several high-profile failures, activity is up among researchers looking to multi-analyte protein assays for monitoring and detection of the disease.
Researchers at the University of Washington have developed a diagnostic platform that leverages the lateral flow immunoassay concept using quantum dots, a mobile phone, and an ultraviolet light-emitting diode.
In a study, Medical Research Council scientists demonstrated that a test that uses flow cytometry and looks for the CD63 protein in mast cells had 98 percent specificity.
Their machine learning technology coupled with digital holography produced an 84 percent success rate in predicting canine responses to chemotherapy.
Neurofilament light protein may be able to determine when an athlete who's suffered a concussion can safely return to playing again, researchers said.
The partners will develop an amyloid β 42/40 ratio assay to identify patients who may benefit from treatment with Janssen's drug called atabecestat.
The firm expects to build out a menu for the reader, which will automate results reporting for colorimetric- and fluorescence-based tests.
Pivoting from a technology that it deemed wasn't robust enough, Confer Health is now designing a platform to enable broad-scale testing at home.